Patents by Inventor Claus Lattemann

Claus Lattemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 21-hydroxylation of steroids
    Patent number: 11965199
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: April 23, 2024
    Assignee: SANOFI
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • 21-hydroxylation of steroids
    Patent number: 11608514
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: March 21, 2023
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • 21-Hydroxylation of Steroids
    Publication number: 20220228189
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Application
    Filed: January 31, 2022
    Publication date: July 21, 2022
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • Method for Producing Recombinant 11-De-O-Methyltomaymycin
    Publication number: 20200216852
    Abstract: The present invention provides a tomaymycin biosynthetic gene cluster of Streptomyces species FH6421, and its use for producing 11-de-O-methyltomaymycm.
    Type: Application
    Filed: December 19, 2019
    Publication date: July 9, 2020
    Inventors: Claus LATTEMANN, Mark BROENSTRUP, Stefan WERNER, Rolf MÜLLER, Kirsten HARMROLS
  • Method for producing recombinant 11-de-O-methyltomaymycin
    Patent number: 10550397
    Abstract: The present invention provides a tomaymycin biosynthetic gene cluster of Streptomyces species FH6421, and its use for producing 11-de-O-methyltomaymycin.
    Type: Grant
    Filed: May 13, 2013
    Date of Patent: February 4, 2020
    Assignee: SANOFI
    Inventors: Claus Lattemann, Mark Broenstrup, Stefan Werner, Rolf Müller, Kirsten Harmrols
  • 21-Hydroxylation of Steroids
    Publication number: 20190352690
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Application
    Filed: June 26, 2019
    Publication date: November 21, 2019
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • 21-hydroxylation of steroids
    Patent number: 10385376
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: August 20, 2019
    Assignee: SANOFI
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • 21-Hydroxylation of Steroids
    Publication number: 20170321241
    Abstract: Generally, the present invention relates to the field of steroid hydroxylation. More specifically, the present invention relates to a method for the 21-hydroxylation of steroids in cells. It also relates to cells expressing a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase, expression vectors comprising a nucleic acid encoding for a steroid 21-hydroxylase and a kit for carrying out the method for the 21-hydroxylation of steroids in cells.
    Type: Application
    Filed: October 29, 2015
    Publication date: November 9, 2017
    Inventors: Claus Lattemann, Thomas Stillger, Bernd Janocha, Hans-Falk Rasser, Sebastian Rissom, Simone Anderko, Rita Bernhardt, Frank Hannemann
  • Method for Producing Recombinant 11-De-O-Methyltomaymycin
    Publication number: 20150111298
    Abstract: The present invention provides a tomaymycin biosynthetic gene cluster of Streptomyces species FH6421, and its use for producing 11-de-O-methyltomaymycin.
    Type: Application
    Filed: May 13, 2013
    Publication date: April 23, 2015
    Applicant: Sanofi
    Inventors: Claus Lattemann, Mark Broenstrup, Stefan Werner, Rolf Müller, Kirsten Harmrols
  • Method for producing carboxy-terminal-amidified peptides
    Patent number: 7939293
    Abstract: The invention relates to the production of carboxy-terminal (C-terminal) amidified peptides with C-terminal amidified lysin, in particular with the biological activity of GLP-1, the chemical and/or biotechnological precursors and intermediate products thereof. The invention also relates to a method for the production and use thereof for producing pharmaceutical products.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: May 10, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Paul Habermann, Heinrich Decker, Claus Lattemann, Oliver Maneg, Christophe Salagnad, Frank Zocher
  • Method For Producing Carboxy-Terminal-Amidified Peptides
    Publication number: 20090005299
    Abstract: The invention relates to the production of carboxy-terminal (C-terminal) amidified peptides with C-terminal amidified lysin, in particular with the biological activity of GLP-1, the chemical and/or biotechnological precursors and intermediate products thereof. The invention also relates to a method for the production and use thereof for producing pharmaceutical products.
    Type: Application
    Filed: November 18, 2005
    Publication date: January 1, 2009
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Paul Habermann, Heinrich Decker, Claus Lattemann, Oliver Maneg, Christophe Salagnad, Frank Zocher